Entrada Therapeutics, Inc.
NASDAQ:TRDABiotechnology
Healthcare
$4.96 +0.37%
+$0.03 today
- Market cap
- $194.19M
- Beta
- -0.26
- P/E (TTM)
- -1.7
- EPS (TTM)
- -$3.97
52W Low $4.93High $16.45
Volume 0.43M
Average 0.36M
Price history
Entrada Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-43.76%
Period high
$16.03
Period low
$4.37
Latest
$4.96
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Oct 14, 2026 | Oct 14, 2026 | |
| SC 13D/A | Sep 10, 2026 | Sep 10, 2026 | |
| 4 | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Aug 31, 2026 | Aug 31, 2026 | |
| 4 | Aug 31, 2026 | Aug 31, 2026 | |
| 4 | Aug 26, 2026 | Aug 26, 2026 |
Competitors
Who does Entrada Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about TRDA's filings, answered from its disclosures.
What is the latest TRDA filing?
The latest filing shown is 10-Q dated Nov 5, 2026.
How many recent filings does TRDA have?
Intrinsic Alpha currently shows 20 recent filings for TRDA.
Continue the stock analysis
Jump to another research area for this company.